Lamotrigin Orion

Lamotrigine, the active ingredient in Lamotrigin Orion, is an anticonvulsant presented as an oral tablet for oral use. It treats epilepsy, including partial and generalized seizures, and is used as maintenance therapy for bipolar disorder, as well as for Lennox‑Gastaut syndrome in appropriate patients.

GNH USA supplies Lamotrigin Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is employed across several neurological and psychiatric conditions where abnormal neuronal excitability is a key factor.

- Epilepsy: reduces the frequency and severity of partial and generalized seizures. - Bipolar disorder: provides maintenance treatment to stabilize mood and prevent relapse. - Lennox‑Gastaut syndrome: decreases the number of seizure episodes in this severe childhood epilepsy.

Lamotrigine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: transient light‑headedness, especially at treatment initiation. - Headache: mild to moderate intensity, often improves with continued therapy. - Nausea: occasional gastrointestinal upset that may lessen over time. - Rash: mild skin irritation or erythema, requiring monitoring.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction with blistering and mucosal involvement. - Toxic epidermal necrolysis: life‑threatening skin detachment requiring immediate medical attention. - Blood dyscrasias: rare cases of aplastic anemia or agranulocytosis. - Hepatic failure: very rare but serious liver injury.

Lamotrigine requires careful consideration of patient‑specific factors and proper handling.

- Pregnancy: Category B; use only when benefits outweigh potential risks. - Renal impairment: dose may need adjustment; monitor renal function. - Hepatic impairment: monitor liver enzymes and consider dose modification. - Concomitant valproic acid: may increase lamotrigine levels; close monitoring required. - Avoid abrupt discontinuation: sudden cessation can precipitate seizures. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Lamotrigine interacts with several agents that can alter its plasma concentration or increase toxicity risk.

Major Interactions (Avoid): - Valproic acid: markedly raises lamotrigine levels; avoid or adjust dose. - Carbamazepine: reduces lamotrigine concentrations, potentially decreasing efficacy. - Phenobarbital: lowers lamotrigine levels, requiring dose reassessment.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may lower lamotrigine levels; monitor seizure control. - Serotonergic agents: potential increased risk of serotonin syndrome. - SSRIs and other antidepressants: observe for rash or hypersensitivity reactions.